Viracta Therapeutics
VIRX
#10423
Rank
A$1.33 M
Marketcap
$0.03358
Share price
-12.61%
Change (1 day)
-97.94%
Change (1 year)

Earnings for Viracta Therapeutics (VIRX)

Earnings in 2024 (TTM): -A$64.18 Million

According to Viracta Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$85.31 Million a decrease over its 2022 earnings that were of -A$82.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viracta Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$64.18 Million-24.77%
2023 -A$85.31 Million3.78%
2022 -A$82.2 Million-57.13%
2021 -A$0.2 Billion503.47%
2020 -A$31.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 230.10%๐Ÿ‡บ๐Ÿ‡ธ USA